Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glutamine N-acyltransferase activity	GLYATL1 GLYATL1B	4.11e-06	2	41	2	GO:0047946
GeneOntologyMolecularFunction	glycine N-acyltransferase activity	GLYATL1 GLYATL1B	4.10e-05	5	41	2	GO:0047961
GeneOntologyMolecularFunction	MAP kinase activity	MAPK14 MAPK11	4.85e-04	16	41	2	GO:0004707
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine phosphatase activity	PTPRM PTPRR	5.49e-04	17	41	2	GO:0005001
GeneOntologyMolecularFunction	transmembrane receptor protein phosphatase activity	PTPRM PTPRR	5.49e-04	17	41	2	GO:0019198
GeneOntologyMolecularFunction	acyltransferase activity, transferring groups other than amino-acyl groups	GLUL GLYATL1 GLYATL1B PAFAH1B2	1.41e-03	238	41	4	GO:0016747
GeneOntologyBiologicalProcess	glutamine metabolic process	GLUL GLYATL1 GLYATL1B	2.65e-05	30	40	3	GO:0006541
GeneOntologyBiologicalProcess	regulation of epithelial cell migration	GLUL DOCK1 MAPK14 PTPRM PTPRR EPHA2	4.90e-05	344	40	6	GO:0010632
GeneOntologyBiologicalProcess	positive regulation of interleukin-12 production	MAPK14 MAPK11 CD36	1.17e-04	49	40	3	GO:0032735
GeneOntologyBiologicalProcess	response to lipoteichoic acid	MAPK14 CD36	1.63e-04	10	40	2	GO:0070391
GeneOntologyBiologicalProcess	cellular response to lipoteichoic acid	MAPK14 CD36	1.63e-04	10	40	2	GO:0071223
GeneOntologyBiologicalProcess	epithelial cell migration	GLUL DOCK1 MAPK14 PTPRM PTPRR EPHA2	1.71e-04	432	40	6	GO:0010631
GeneOntologyBiologicalProcess	epithelium migration	GLUL DOCK1 MAPK14 PTPRM PTPRR EPHA2	1.78e-04	435	40	6	GO:0090132
GeneOntologyBiologicalProcess	tissue migration	GLUL DOCK1 MAPK14 PTPRM PTPRR EPHA2	1.91e-04	441	40	6	GO:0090130
GeneOntologyBiologicalProcess	cellular response to UV-B	MAPK14 MAPK11	2.39e-04	12	40	2	GO:0071493
GeneOntologyBiologicalProcess	regulation of interleukin-12 production	MAPK14 MAPK11 CD36	3.52e-04	71	40	3	GO:0032655
GeneOntologyBiologicalProcess	interleukin-12 production	MAPK14 MAPK11 CD36	3.82e-04	73	40	3	GO:0032615
Domain	FN3_dom	IFNGR1 IL20RA ASTN2 POMGNT2 PTPRM EPHA2	5.11e-06	209	40	6	IPR003961
Domain	MAPK_p38	MAPK14 MAPK11	2.68e-05	4	40	2	IPR008352
Domain	FN3	IL20RA ASTN2 POMGNT2 PTPRM EPHA2	6.35e-05	199	40	5	PS50853
Domain	MAP_kinase_CS	MAPK14 MAPK11	2.91e-04	12	40	2	IPR003527
Domain	Tissue_fac	IFNGR1 IL20RA	2.91e-04	12	40	2	PF01108
Domain	MAPK	MAPK14 MAPK11	2.91e-04	12	40	2	PS01351
Domain	Tissue_factor	IFNGR1 IL20RA	2.91e-04	12	40	2	IPR001187
Domain	Kinase-like_dom	STK36 MAPK14 MAPK11 PIK3C2G EPHA2 NIM1K	9.63e-04	542	40	6	IPR011009
Domain	Cupredoxin	CP PADI4	1.01e-03	22	40	2	IPR008972
Domain	Protein_kinase_ATP_BS	STK36 MAPK14 MAPK11 EPHA2 NIM1K	1.23e-03	379	40	5	IPR017441
Domain	-	IFNGR1 IL20RA ASTN2 POMGNT2 PTPRM EPHA2	2.68e-03	663	40	6	2.60.40.10
Domain	PTPc	PTPRM PTPRR	2.69e-03	36	40	2	SM00194
Domain	PROTEIN_KINASE_ATP	STK36 MAPK14 MAPK11 EPHA2 NIM1K	2.84e-03	459	40	5	PS00107
Domain	TYR_PHOSPHATASE_PTP	PTPRM PTPRR	3.15e-03	39	40	2	PS50055
Domain	PTPase_domain	PTPRM PTPRR	3.48e-03	41	40	2	IPR000242
Domain	Y_phosphatase	PTPRM PTPRR	3.48e-03	41	40	2	PF00102
Domain	Ig-like_fold	IFNGR1 IL20RA ASTN2 POMGNT2 PTPRM EPHA2	3.66e-03	706	40	6	IPR013783
Domain	Prot_kinase_dom	STK36 MAPK14 MAPK11 EPHA2 NIM1K	3.73e-03	489	40	5	IPR000719
Domain	BTB-kelch_protein	KLHL12 KLHL23	3.82e-03	43	40	2	IPR017096
Domain	PROTEIN_KINASE_DOM	STK36 MAPK14 MAPK11 EPHA2 NIM1K	3.86e-03	493	40	5	PS50011
Domain	Kelch	KLHL12 KLHL23	6.85e-03	58	40	2	SM00612
Domain	Ser/Thr_kinase_AS	STK36 MAPK14 MAPK11 NIM1K	6.97e-03	357	40	4	IPR008271
Domain	PTPc_motif	PTPRM PTPRR	7.08e-03	59	40	2	SM00404
Domain	Tyr_Pase_cat	PTPRM PTPRR	7.08e-03	59	40	2	IPR003595
Domain	Gal_Oxase/kelch_b-propeller	KLHL12 KLHL23	7.08e-03	59	40	2	IPR011043
Domain	S_TKc	STK36 MAPK14 MAPK11 NIM1K	7.11e-03	359	40	4	SM00220
Domain	FN3	ASTN2 PTPRM EPHA2	7.22e-03	185	40	3	SM00060
Domain	BACK	KLHL12 KLHL23	7.32e-03	60	40	2	SM00875
Domain	PROTEIN_KINASE_ST	STK36 MAPK14 MAPK11 NIM1K	7.32e-03	362	40	4	PS00108
Domain	BACK	KLHL12 KLHL23	7.56e-03	61	40	2	PF07707
Domain	BACK	KLHL12 KLHL23	7.56e-03	61	40	2	IPR011705
Pathway	WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING	IFNGR1 IL20RA MAPK14 MAPK11	2.44e-05	78	31	4	M39824
Pathway	KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY	MAPK14 MAPK11	6.98e-05	6	31	2	M47766
Pathway	BIOCARTA_TSP1_PATHWAY	MAPK14 CD36	9.76e-05	7	31	2	M22039
Pathway	BIOCARTA_TSP1_PATHWAY	MAPK14 CD36	9.76e-05	7	31	2	MM1559
Pathway	REACTOME_P38MAPK_EVENTS	MAPK14 MAPK11	9.76e-05	7	31	2	MM14672
Pathway	WP_IL26_SIGNALING	MPO IL20RA MAPK14	1.46e-04	47	31	3	M48074
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	MAPK14 MAPK11	2.08e-04	10	31	2	MM15135
Pathway	REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION	MAPK14 MAPK11	2.08e-04	10	31	2	M27146
Pathway	REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS	MAPK14 MAPK11	2.08e-04	10	31	2	M13962
Pathway	REACTOME_SIGNALLING_TO_RAS	MAPK14 MAPK11	3.05e-04	12	31	2	MM14657
Pathway	REACTOME_P38MAPK_EVENTS	MAPK14 MAPK11	3.60e-04	13	31	2	M1441
Pathway	KEGG_LEISHMANIA_INFECTION	IFNGR1 MAPK14 MAPK11	5.18e-04	72	31	3	M3126
Pathway	WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3	IFNGR1 MAPK14 MAPK11	5.84e-04	75	31	3	M39568
Pathway	REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA	MAPK14 MAPK11	6.24e-04	17	31	2	M959
Pathway	REACTOME_ERK_MAPK_TARGETS	MAPK14 MAPK11	7.82e-04	19	31	2	MM14780
Pathway	REACTOME_SIGNALLING_TO_RAS	MAPK14 MAPK11	8.68e-04	20	31	2	M12256
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP	MAPK14 PTPRR	8.68e-04	20	31	2	M47928
Pathway	PID_P38_MK2_PATHWAY	MAPK14 MAPK11	9.58e-04	21	31	2	M199
Pathway	BIOCARTA_NTHI_PATHWAY	MAPK14 MAPK11	1.05e-03	22	31	2	MM1443
Pathway	WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS	MAPK14 MAPK11	1.05e-03	22	31	2	M39902
Pathway	REACTOME_ERK_MAPK_TARGETS	MAPK14 MAPK11	1.05e-03	22	31	2	M13408
Pathway	WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING	MAPK14 MAPK11	1.15e-03	23	31	2	M39709
Pathway	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	MAPK14 MAPK11	1.15e-03	23	31	2	M17243
Pathway	WP_LDL_INFLUENCE_ON_CD14_AND_TLR4	MAPK14 MAPK11	1.15e-03	23	31	2	M45556
Pathway	BIOCARTA_NTHI_PATHWAY	MAPK14 MAPK11	1.15e-03	23	31	2	M2821
Pathway	WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART	MAPK14 MAPK11	1.25e-03	24	31	2	M39576
Pathway	REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	MAPK14 MAPK11	1.25e-03	24	31	2	MM15133
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	MAPK14 MAPK11	1.25e-03	24	31	2	M27553
Pathway	REACTOME_MYOGENESIS	MAPK14 MAPK11	1.25e-03	24	31	2	MM15174
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES	MAPK14 MAPK11	1.36e-03	25	31	2	MM15269
Pathway	PID_LYMPH_ANGIOGENESIS_PATHWAY	MAPK14 MAPK11	1.36e-03	25	31	2	M274
Pathway	REACTOME_SIGNALING_BY_VEGF	DOCK1 MAPK14 MAPK11	1.47e-03	103	31	3	MM14752
Pathway	REACTOME_SIGNALLING_TO_ERKS	MAPK14 MAPK11	1.47e-03	26	31	2	MM14716
Pathway	PID_P38_MKK3_6PATHWAY	MAPK14 MAPK11	1.47e-03	26	31	2	M20
Pathway	KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY	MAPK14 MAPK11	1.47e-03	26	31	2	M47565
Pathway	WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION	MAPK14 MAPK11	1.59e-03	27	31	2	M39838
Pathway	REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION	MAPK14 MAPK11	1.59e-03	27	31	2	MM14779
Pathway	REACTOME_SIGNALING_BY_VEGF	DOCK1 MAPK14 MAPK11	1.59e-03	106	31	3	M27077
Pathway	WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING	MAPK14 MAPK11	1.71e-03	28	31	2	M39572
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	MAPK14 MAPK11	1.71e-03	28	31	2	MM15132
Pathway	WP_IL19_SIGNALING	IL20RA MAPK14	1.71e-03	28	31	2	M48111
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	MAPK14 MAPK11	1.83e-03	29	31	2	M39676
Pathway	REACTOME_MYOGENESIS	MAPK14 MAPK11	1.83e-03	29	31	2	M853
Pathway	PID_P38_ALPHA_BETA_PATHWAY	MAPK14 MAPK11	1.96e-03	30	31	2	M76
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE	MAPK14 MAPK11 CD36	2.01e-03	115	31	3	M27013
Pathway	PID_CD40_PATHWAY	MAPK14 MAPK11	2.09e-03	31	31	2	M45
Pathway	REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES	MAPK14 MAPK11	2.09e-03	31	31	2	M15195
Pathway	WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES	MAPK14 MAPK11 PIK3C2G	2.17e-03	118	31	3	M39852
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY	MAPK14 MAPK11	2.37e-03	33	31	2	M47550
Pathway	REACTOME_NOD1_2_SIGNALING_PATHWAY	MAPK14 MAPK11	2.37e-03	33	31	2	MM14663
Pathway	BIOCARTA_FMLP_PATHWAY	MAPK14 PIK3C2G	2.51e-03	34	31	2	M10287
Pathway	SIG_CD40PATHWAYMAP	MAPK14 MAPK11	2.51e-03	34	31	2	M12705
Pathway	REACTOME_SIGNALLING_TO_ERKS	MAPK14 MAPK11	2.51e-03	34	31	2	M13881
Pathway	BIOCARTA_FMLP_PATHWAY	MAPK14 PIK3C2G	2.51e-03	34	31	2	MM1399
Pathway	REACTOME_NOD1_2_SIGNALING_PATHWAY	MAPK14 MAPK11	2.81e-03	36	31	2	M1059
Pathway	WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING	MAPK14 MAPK11	2.81e-03	36	31	2	M39908
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	MAPK14 MAPK11	2.97e-03	37	31	2	MM14899
Pathway	WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY	MAPK14 MAPK11 PIK3C2G	2.98e-03	132	31	3	M39338
Pathway	PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY	MAPK14 MAPK11	3.13e-03	38	31	2	M229
Pathway	PID_FAS_PATHWAY	MAPK14 MAPK11	3.13e-03	38	31	2	M94
Pathway	REACTOME_NEUTROPHIL_DEGRANULATION	MPO MAPK14 ACTR2 CD36 PAFAH1B2	3.60e-03	478	31	5	M27620
Pathway	PID_CXCR3_PATHWAY	MAPK14 MAPK11	4.00e-03	43	31	2	M222
Pathway	REACTOME_DEVELOPMENTAL_BIOLOGY	DOCK1 MAPK14 MAPK11 ACTR2 EPHA2	4.43e-03	502	31	5	MM14537
Pathway	REACTOME_TOLL_LIKE_RECEPTOR_CASCADES	MAPK14 MAPK11 CD36	4.68e-03	155	31	3	MM14665
Pathway	WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE	MAPK14 MAPK11	4.76e-03	47	31	2	M39518
Pathway	PID_IL6_7_PATHWAY	MAPK14 MAPK11	4.76e-03	47	31	2	M183
Pathway	REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	MAPK14 MAPK11	4.76e-03	47	31	2	MM14664
Pathway	REACTOME_NEUTROPHIL_DEGRANULATION	MPO MAPK14 ACTR2 CD36 PAFAH1B2	4.78e-03	511	31	5	MM15330
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	MPO DOCK1 MAPK14 MAPK11 ACTR2 CD36 PAFAH1B2	5.02e-03	995	31	7	MM14661
Pathway	WP_INSULIN_SIGNALING	MAPK14 MAPK11 PIK3C2G	5.11e-03	160	31	3	M39482
Pathway	WP_INSULIN_SIGNALING	MAPK14 MAPK11 PIK3C2G	5.11e-03	160	31	3	MM15956
Pathway	WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY	MAPK14 MAPK11	5.16e-03	49	31	2	M39543
Pubmed	Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation.	MAPK14 MAPK11	1.36e-06	2	41	2	29357353
Pubmed	Counter-regulation of T cell effector function by differentially activated p38.	MAPK14 MAPK11	1.36e-06	2	41	2	24863062
Pubmed	Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?	MPO CP	1.36e-06	2	41	2	9097926
Pubmed	Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.	MPO CD36	1.36e-06	2	41	2	10772654
Pubmed	Intrinsically active variants of all human p38 isoforms.	MAPK14 MAPK11	1.36e-06	2	41	2	17241234
Pubmed	A Mutation in Syne2 Causes Early Retinal Defects in Photoreceptors, Secondary Neurons, and Müller Glia.	IFNGR1 SYNE2	1.36e-06	2	41	2	26066746
Pubmed	p38 (Mapk14/11) occupies a regulatory node governing entry into primitive endoderm differentiation during preimplantation mouse embryo development.	MAPK14 MAPK11	1.36e-06	2	41	2	27605380
Pubmed	p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting.	MAPK14 MAPK11	1.36e-06	2	41	2	19955483
Pubmed	The p38alpha/beta MAPK functions as a molecular switch to activate the quiescent satellite cell.	MAPK14 MAPK11	1.36e-06	2	41	2	15824134
Pubmed	The activation of p38 alpha, and not p38 beta, mitogen-activated protein kinase is required for ischemic preconditioning.	MAPK14 MAPK11	1.36e-06	2	41	2	20188737
Pubmed	Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation.	MAPK14 MAPK11	1.36e-06	2	41	2	17105766
Pubmed	p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice.	MAPK14 MAPK11	1.36e-06	2	41	2	24531379
Pubmed	p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart.	MAPK14 MAPK11	1.36e-06	2	41	2	32573492
Pubmed	Effect of p38 MAP kinases on contractility and ischemic injury in intact heart.	MAPK14 MAPK11	1.36e-06	2	41	2	19706373
Pubmed	Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.	MPO CP	1.36e-06	2	41	2	23306200
Pubmed	Roles of p38α and p38β mitogen‑activated protein kinase isoforms in human malignant melanoma A375 cells.	MAPK14 MAPK11	1.36e-06	2	41	2	31661126
Pubmed	Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other.	MPO CP	1.36e-06	2	41	2	19031316
Pubmed	p38α and p38β mitogen-activated protein kinases determine cholinergic transdifferentiation of sympathetic neurons.	MAPK14 MAPK11	1.36e-06	2	41	2	21865449
Pubmed	EphA2 modulates radiosensitive of hepatocellular carcinoma cells via p38/mitogen-activated protein kinase-mediated signal pathways.	MAPK14 EPHA2	1.36e-06	2	41	2	26520689
Pubmed	Interferon-alpha induces the growth inhibition of human T-cell leukaemia line Jurkat through p38alpha and p38beta.	MAPK14 MAPK11	1.36e-06	2	41	2	20053787
Pubmed	The protein tyrosine kinase SYK regulates the alternative p38 activation in liver during acute liver inflammation.	MAPK14 MAPK11	4.06e-06	3	41	2	31780731
Pubmed	Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells.	MAPK14 MAPK11	4.06e-06	3	41	2	24673557
Pubmed	The p38alpha/beta mitogen-activated protein kinases mediate recruitment of CREB-binding protein to preserve fast myosin heavy chain IId/x gene activity in myotubes.	MAPK14 MAPK11	4.06e-06	3	41	2	17210568
Pubmed	Relationship between maternal blood ceruloplasmin level, catalase and myeloperoxidase activity and neural tube defects.	MPO CP	4.06e-06	3	41	2	28397206
Pubmed	Study of interaction of ceruloplasmin, lactoferrin, and myeloperoxidase by photon correlation spectroscopy.	MPO CP	4.06e-06	3	41	2	19916937
Pubmed	Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38.	MAPK14 MAPK11	4.06e-06	3	41	2	15304097
Pubmed	Astrocytic p38α MAPK drives NMDA receptor-dependent long-term depression and modulates long-term memory.	MAPK14 MAPK11	4.06e-06	3	41	2	31273206
Pubmed	The differential regulation of p38α by the neuronal kinase interaction motif protein tyrosine phosphatases, a detailed molecular study.	MAPK14 PTPRR	4.06e-06	3	41	2	23932588
Pubmed	TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.	MAPK14 MAPK11	4.06e-06	3	41	2	22522454
Pubmed	The transcriptional activator Mirk/Dyrk1B is sequestered by p38alpha/beta MAP kinase.	MAPK14 MAPK11	4.06e-06	3	41	2	12384504
Pubmed	Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation.	MAPK14 MAPK11	4.06e-06	3	41	2	17855341
Pubmed	Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation.	MAPK14 MAPK11	4.06e-06	3	41	2	21715315
Pubmed	Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.	MAPK14 MAPK11	4.06e-06	3	41	2	15273249
Pubmed	Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation.	MAPK14 MAPK11	4.06e-06	3	41	2	18256287
Pubmed	Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate.	MAPK14 MAPK11	4.06e-06	3	41	2	21336470
Pubmed	Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release.	MAPK14 MAPK11	4.06e-06	3	41	2	11495898
Pubmed	Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.	MAPK14 MAPK11	4.06e-06	3	41	2	20162623
Pubmed	Dioscin attenuates oxLDL uptake and the inflammatory reaction of dendritic cells under high glucose conditions by blocking p38 MAPK.	MAPK14 CD36	4.06e-06	3	41	2	31746382
Pubmed	p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts.	MAPK14 MAPK11	4.06e-06	3	41	2	16364914
Pubmed	Phosphorylation of SNX27 by MAPK11/14 links cellular stress-signaling pathways with endocytic recycling.	MAPK14 MAPK11	4.06e-06	3	41	2	33605979
Pubmed	Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.	MAPK14 CD36	4.06e-06	3	41	2	17761940
Pubmed	Protein arginine methyltransferase 1 interacts with and activates p38α to facilitate erythroid differentiation.	MAPK14 MAPK11	4.06e-06	3	41	2	23483889
Pubmed	Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium.	MPO CP	4.06e-06	3	41	2	27903408
Pubmed	Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light.	MAPK14 MAPK11	8.12e-06	4	41	2	15708845
Pubmed	Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions.	MPO PADI4	8.12e-06	4	41	2	33391487
Pubmed	Essential role for p38alpha MAPK but not p38gamma MAPK in Igf2 expression and myoblast differentiation.	MAPK14 MAPK11	8.12e-06	4	41	2	20610565
Pubmed	Role for mitogen-activated protein kinase p38 alpha in lung epithelial branching morphogenesis.	MAPK14 MAPK11	8.12e-06	4	41	2	18177852
Pubmed	Identification of core gene in obese type 2 diabetes patients using bioinformatics analysis.	GLUL CD36	8.12e-06	4	41	2	34085602
Pubmed	Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors.	MAPK14 MAPK11	8.12e-06	4	41	2	10330143
Pubmed	Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.	IFNGR1 PADI4	8.12e-06	4	41	2	24425713
Pubmed	A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.	MAPK14 PTPRR	8.12e-06	4	41	2	10601328
Pubmed	p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration.	MAPK14 MAPK11	8.12e-06	4	41	2	17139251
Pubmed	p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice.	MAPK14 MAPK11	8.12e-06	4	41	2	19936205
Pubmed	Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK.	MAPK14 MAPK11	8.12e-06	4	41	2	15728454
Pubmed	Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.	MAPK14 MAPK11	8.12e-06	4	41	2	20188673
Pubmed	TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.	MAPK14 MAPK11	8.12e-06	4	41	2	24161934
Pubmed	Murine p38-delta mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines.	MAPK14 MAPK11	8.12e-06	4	41	2	10066767
Pubmed	Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction.	MAPK14 MAPK11	8.12e-06	4	41	2	28011639
Pubmed	Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.	MAPK14 MAPK11	8.12e-06	4	41	2	26479921
Pubmed	Effects of paraoxonase, arylesterase, ceruloplasmin, catalase, and myeloperoxidase activities on prognosis in pediatric patients with sepsis.	MPO CP	8.12e-06	4	41	2	28167245
Pubmed	Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.	MAPK14 MAPK11	8.12e-06	4	41	2	23568773
Pubmed	Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.	MAPK14 MAPK11	8.12e-06	4	41	2	20378550
Pubmed	Bacterial Siderophores Hijack Neutrophil Functions.	MPO PADI4	8.12e-06	4	41	2	28432145
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	GLUL TRHDE PTPRR SUPT5H EPHA2 DHX38	9.41e-06	420	41	6	28065597
Pubmed	The stress-activated protein kinases p38α/β and JNK1/2 cooperate with Chk1 to inhibit mitotic entry upon DNA replication arrest.	MAPK14 MAPK11	1.35e-05	5	41	2	22935704
Pubmed	Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo.	MAPK14 MAPK11	1.35e-05	5	41	2	17074887
Pubmed	Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci.	TRHDE PADI4	1.35e-05	5	41	2	21452313
Pubmed	A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis.	MAPK14 MAPK11	1.35e-05	5	41	2	17380123
Pubmed	p38α MAPK proximity assay reveals a regulatory mechanism of alternative splicing in cardiomyocytes.	MAPK14 MAPK11	1.35e-05	5	41	2	31505169
Pubmed	ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome.	MAPK14 MAPK11	1.35e-05	5	41	2	35857590
Pubmed	Interleukin-3 stimulation of mcl-1 gene transcription involves activation of the PU.1 transcription factor through a p38 mitogen-activated protein kinase-dependent pathway.	MAPK14 MAPK11	1.35e-05	5	41	2	12612065
Pubmed	Evidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assembly.	MAPK14 MAPK11	1.35e-05	5	41	2	15632108
Pubmed	Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.	MAPK14 MAPK11	1.35e-05	5	41	2	28864471
Pubmed	Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation.	MAPK14 MAPK11	1.35e-05	5	41	2	17304211
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GLUL MPO MAPK14 MAPK11 PTPRM PTPRR SUPT5H EPHA2	1.55e-05	974	41	8	28675297
Pubmed	Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.	MAPK14 MAPK11	2.03e-05	6	41	2	27856911
Pubmed	Up-regulation of galectin-9 induces cell migration in human dendritic cells infected with dengue virus.	MAPK14 MAPK11	2.03e-05	6	41	2	25754930
Pubmed	Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases.	MAPK14 MAPK11	2.03e-05	6	41	2	15735648
Pubmed	Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation.	MAPK14 MAPK11	2.03e-05	6	41	2	22231518
Pubmed	Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta.	MAPK14 MAPK11	2.03e-05	6	41	2	14680475
Pubmed	The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice.	MAPK14 MAPK11	2.84e-05	7	41	2	20551513
Pubmed	Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.	MPO CD36	2.84e-05	7	41	2	18272685
Pubmed	p38 MAPK signalling cascades: ancient roles and new functions.	MAPK14 MAPK11	2.84e-05	7	41	2	10878576
Pubmed	A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiation.	MAPK14 MAPK11	2.84e-05	7	41	2	18678706
Pubmed	A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs.	MAPK14 MAPK11	3.78e-05	8	41	2	11359773
Pubmed	F-box Protein βTrCP1 Is a Substrate of Extracellular Signal-regulated Kinase 2.	MAPK14 MAPK11	3.78e-05	8	41	2	34703820
Pubmed	Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN.	MAPK14 MAPK11	3.78e-05	8	41	2	12761180
Pubmed	Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.	MAPK14 MAPK11	3.78e-05	8	41	2	9155017
Pubmed	Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2.	MAPK14 MAPK11	3.78e-05	8	41	2	11551945
Pubmed	Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling.	MAPK14 MAPK11	4.86e-05	9	41	2	23979601
Pubmed	p38-2, a novel mitogen-activated protein kinase with distinct properties.	MAPK14 MAPK11	4.86e-05	9	41	2	9235954
Pubmed	HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.	MAPK14 PIK3C2G	7.41e-05	11	41	2	16081599
Pubmed	OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc.	MAPK14 EPHA2	7.41e-05	11	41	2	28628118
Pubmed	Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages.	MAPK14 CD36	8.88e-05	12	41	2	17167049
Pubmed	Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.	MAPK14 MAPK11	8.88e-05	12	41	2	12171600
Pubmed	The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.	MAPK14 MAPK11	1.05e-04	13	41	2	17906618
Pubmed	Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.	MAPK14 MAPK11	1.22e-04	14	41	2	9687510
Pubmed	gp120-mediated induction of the MAPK cascade is dependent on the activation state of CD4(+) lymphocytes.	MAPK14 MAPK11	1.22e-04	14	41	2	12239168
Pubmed	Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC.	SUPT5H PAFAH1B2	1.22e-04	14	41	2	22354037
Pubmed	PRAK, a novel protein kinase regulated by the p38 MAP kinase.	MAPK14 MAPK11	1.41e-04	15	41	2	9628874
Interaction	SLX4IP interactions	IFNGR1 FBXW4 MAPK14 SYNE2	7.28e-06	63	40	4	int:SLX4IP
Interaction	ZFP36L1 interactions	MAPK14 PAFAH1B2 KLHL23	2.83e-05	30	40	3	int:ZFP36L1
Interaction	KLHL17 interactions	DOCK1 KLHL12 KLHL23	4.15e-05	34	40	3	int:KLHL17
Cytoband	6q23.3	IFNGR1 IL20RA	2.90e-04	28	41	2	6q23.3
Cytoband	2q31.1	PHOSPHO2 KLHL23	2.59e-03	84	41	2	2q31.1
GeneFamily	Mitogen-activated protein kinases	MAPK14 MAPK11	1.54e-04	13	26	2	651
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRM PTPRR	4.11e-04	21	26	2	813
GeneFamily	Fibronectin type III domain containing	ASTN2 PTPRM EPHA2	1.52e-03	160	26	3	555
GeneFamily	Kelch like\|BTB domain containing	KLHL12 KLHL23	1.65e-03	42	26	2	617
GeneFamily	Sterile alpha motif domain containing	WDSUB1 EPHA2	7.06e-03	88	26	2	760
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL12 KLHL23	1.58e-02	134	26	2	861
CoexpressionAtlas	Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3	GLUL DOCK1 CP PADI4 PTPRM ABCA9 EPHA2 CD36	1.33e-06	438	40	8	GSM605850_500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	MPO DOCK1 TMEM131 MAPK14 ATRX DHX38 KLHL23	2.43e-05	469	40	7	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_1000	MPO DOCK1 IFNGR1 MAPK11 ATRX PTPRM ABCA9 CD36	7.29e-05	761	40	8	gudmap_developingKidney_e15.5_Endothelial cells_1000
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 TRHDE ASTN2 CFAP54 SYNE2	8.66e-07	191	41	5	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IFNGR1 CP PTPRR CD36 SYNE2	1.01e-06	197	41	5	66339b5aae3952f5c484c9dcb0cfb4fbd828d4cb
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA TMEM131 POMGNT2 EPHA2	1.96e-05	174	41	4	a9f34d1237f335d27c5560ff514368f4709f9144
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	IFNGR1 IL20RA ABCA9 CD36	2.00e-05	175	41	4	16849ea8f0985108baa2085f34c3de14a4f9f28b
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA TMEM131 POMGNT2 EPHA2	2.05e-05	176	41	4	d43d9e86c4d4fa1e88fbf2b899ac7143717aac90
ToppCell	lung\|World / shred on tissue and cell subclass	GLUL CP CD36 SYNE2	2.14e-05	178	41	4	7b1e371272328d6b6c3994382d64281ffc737db2
ToppCell	COVID-19-kidney-PCT-S1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRHDE GLYATL1 ASTN2 SYNE2	2.38e-05	183	41	4	6878d14026c3df6aa12e45dfad94b32fa9d9b0b7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 PIK3C2G ANO3	2.44e-05	184	41	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 PIK3C2G ANO3	2.44e-05	184	41	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 PIK3C2G ANO3	2.44e-05	184	41	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 STK36 CFAP54 CD36	2.49e-05	185	41	4	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 CFAP54 SYNE2	2.54e-05	186	41	4	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 CFAP54 SYNE2	2.59e-05	187	41	4	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM PTPRR EPHA2 CD36	2.65e-05	188	41	4	ed11e26ff4ef3d6314b5f5734062519b9aa285c1
ToppCell	facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM PTPRR EPHA2 CD36	2.65e-05	188	41	4	e5a8ca4613ab0bf1584b9e78959adf41d0bf379f
ToppCell	facs-Heart-LV-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRM PTPRR EPHA2 CD36	2.65e-05	188	41	4	0fc3a6562e6895f6fe7a93397eae842a75c60c93
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE GTF2IRD1 PIK3C2G ABCA9	2.71e-05	189	41	4	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	3'_v3-bone_marrow\|World / Manually curated celltypes from each tissue	MPO PADI4 ACTR2 SYNE2	2.82e-05	191	41	4	7b759831f1b1c8575c31f67d0d9eb11c6a833cf3
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IFNGR1 MAPK11 PTPRM CD36	3.00e-05	194	41	4	622461e5f9c648252a2f6ec84e7565220a803132
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.18e-05	197	41	4	ffaf2d7b6aa82008bd64a691b48113626343872c
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	CP EPHA2 SYNE2 NIM1K	3.18e-05	197	41	4	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.18e-05	197	41	4	94e2cc7ec531e58b8ed7e5601fdf8c4bbc3582c8
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.24e-05	198	41	4	c79c1738560d78b63dbed5f2f9621dbc1c2363cb
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH2 CP CFAP54 ANO3	3.24e-05	198	41	4	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.24e-05	198	41	4	1d1c80569f1e307285ba0ebaf5c72e0b5b538864
ToppCell	systemic_lupus_erythematosus-treated-Myeloid\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.24e-05	198	41	4	f37578f156e8aed2ce30cfa837ae04dd18de05d0
ToppCell	systemic_lupus_erythematosus-flare-Myeloid\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	GLUL IFNGR1 ACTR2 CD36	3.24e-05	198	41	4	189346c5eb715f3be427bec3b8e067ababb5b475
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH2 CP CFAP54 ANO3	3.24e-05	198	41	4	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-promonocyte\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MPO PADI4 MAPK14 ACTR2	3.24e-05	198	41	4	ff634a17195d06a8614ed1c6564937d10ca5c00d
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Airway-Club\|Control_saline / Treatment groups by lineage, cell group, cell type	CP PIK3C2G ANO3 EPHA2	3.31e-05	199	41	4	5cc8b553a58669a30eb10845beb23983dcdf5a6a
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GLUL IFNGR1 CP CD36	3.31e-05	199	41	4	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GLUL IFNGR1 CP CD36	3.31e-05	199	41	4	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GLUL IFNGR1 CP CD36	3.31e-05	199	41	4	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATRX PTPRM CD36 SYNE2	3.37e-05	200	41	4	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	IFNGR1 CP CD36 SYNE2	3.37e-05	200	41	4	46dac23d8f9d426fe52ad6dac9c15ce91e615762
ToppCell	COVID_vent-Myeloid\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GLUL IFNGR1 PADI4 CD36	3.37e-05	200	41	4	621af09aae34226902c03edf556562f3ab35a7d8
ToppCell	COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil\|COVID-19_Severe / Disease, condition lineage and cell class	MPO PADI4 MAPK14 ACTR2	3.37e-05	200	41	4	cbe667eda1af222467df8bfa157aa22df488f133
ToppCell	COVID_vent-Myeloid-Monocytic\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GLUL IFNGR1 PADI4 CD36	3.37e-05	200	41	4	b0a5bee87700ce38f26f95a6f491da7e27cade51
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ATRX PTPRM CD36 SYNE2	3.37e-05	200	41	4	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	severe-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MPO PADI4 MAPK14 ACTR2	3.37e-05	200	41	4	5ee43386da8261d2e7602a152e6ba4338d844e08
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MPO PADI4 MAPK14 CD36	3.37e-05	200	41	4	a3f22826f3d8f917ff0594bdadd93b60763bcaa2
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IFNGR1 MAPK11 PTPRM CD36	3.37e-05	200	41	4	663e2b4672f193844bb9bf4873749114977c19b3
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE ASTN2 ABCA9	2.07e-04	125	41	3	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	facs-Aorta-Heart-3m-Endothelial-coronary_vascular_endothelial_cell\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO MAPK11 PTPRR	2.43e-04	132	41	3	dc13b54e38fbda9341972cef11833041f2f2a345
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 PHOSPHO2	2.59e-04	135	41	3	8521107817df49efd9a2e81078c8535ed33e729c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 CFAP54	3.07e-04	143	41	3	7a7a9829ba63468c9745904d9e993590051207ab
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	STK36 CFAP54 PTPRM	3.53e-04	150	41	3	b6f1fc62d08199fed6156c7cd32f66d9926531b5
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA PADI4 PTPRR	3.67e-04	152	41	3	d5ba87b5d34e52cef8475befafea962d70fa8a1d
ToppCell	droplet-Liver-LIVER_HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA PADI4 PTPRR	3.67e-04	152	41	3	d88d68a788a3256671ebbc06e104833f1f58f07d
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	STK36 MAPK11 PTPRR	3.81e-04	154	41	3	e65e4636646164610f33f7bbac0d879a3ea55986
ToppCell	Control-Endothelial-Epi-like\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLUL PADI4 EPHA2	4.03e-04	157	41	3	4d02c50d5d1b892ea241e98724386d8a5a156a46
ToppCell	Control-Endothelial-Epi-like-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLUL PADI4 EPHA2	4.03e-04	157	41	3	2c369660c752c0fb3bd798a561d3359e2f9aa983
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE PADI4 ANO3	4.11e-04	158	41	3	551e3fd7cabc94ba933607ccdcf93f4e799be43a
ToppCell	droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 PADI4 DHX38	4.26e-04	160	41	3	984990be02642a562f0c60ea99c01f005e7c02c2
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CP PTPRR EPHA2	4.34e-04	161	41	3	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRHDE CP SYNE2	4.34e-04	161	41	3	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ASTN2 PHOSPHO2 GTF2IRD1	4.42e-04	162	41	3	373513f9d0e5007b2e10a8b78d4909dcce9e3b62
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	IL20RA MAPK11 ANO3	4.50e-04	163	41	3	218b9ba099cb27aa91c6b73bf89b44895f5dddc3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH2 CFAP54 ANO3	4.58e-04	164	41	3	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 SYNE2	4.58e-04	164	41	3	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 GTF2IRD1	4.58e-04	164	41	3	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO TRHDE ABCA9	4.66e-04	165	41	3	6d315e0734079ad05336cc2c3f24d870c9105bc8
ToppCell	facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO TRHDE ABCA9	4.66e-04	165	41	3	84f5597b1bb75f42de9a224196bb8ac198bbe3bf
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CP PTPRR ABCA9	4.74e-04	166	41	3	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CP PTPRR ABCA9	4.74e-04	166	41	3	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	LPS-antiTNF-Epithelial_airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP PTPRR ANO3	4.74e-04	166	41	3	eb942ed68677e55c46cb039046f45686d4062d7c
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP PTPRR ANO3	4.74e-04	166	41	3	1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d
ToppCell	LPS-antiTNF-Epithelial_airway-Club_cells-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP PTPRR ANO3	4.74e-04	166	41	3	9628522e7af8f8edca733588a364ab2454ac5ca5
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CP PTPRR ABCA9	4.74e-04	166	41	3	4586d6725403f879fc96f67be579022587ce1906
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH2 IFNGR1 CD36	4.91e-04	168	41	3	e979a4fbeb9f21048b47d69e6da75c57650697f2
ToppCell	facs-Heart-LV-24m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PTPRR CD36	5.00e-04	169	41	3	6a31a940a8474fb087d8fe7193a6974a72e0a014
ToppCell	facs-Heart-LV-24m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PTPRR CD36	5.00e-04	169	41	3	39d627763abd57e53edb1169832b47cfb3e8c274
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP PTPRR ANO3	5.00e-04	169	41	3	8c96e1baa38ec5e777e627ab9dbce025e771f2c0
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Club_cells-Airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CP PTPRR ANO3	5.00e-04	169	41	3	86041be5d3aeab5b9269f7912791b944f325a1b4
ToppCell	facs-Heart-LV-24m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PTPRR CD36	5.00e-04	169	41	3	b85927a256790402e9fc12ebcadd83e4e2afd2ce
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CP ABCA9 ANO3	5.08e-04	170	41	3	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MPO PADI4 MAPK14	5.08e-04	170	41	3	cf22a843ae2d9cd6693507fed2b7c6a45abea10e
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAPK11 PIK3C2G PTPRR	5.08e-04	170	41	3	55fe16d98ea284d05fb899888e4569c685644c7b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CP ABCA9 ANO3	5.08e-04	170	41	3	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE PIK3C2G ANO3	5.08e-04	170	41	3	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	IL20RA CP CFAP54	5.17e-04	171	41	3	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic\|GI_small-bowel / Manually curated celltypes from each tissue	GLUL PADI4 CD36	5.17e-04	171	41	3	098a7fd387357c0d4e1a6169af4d24ef95b30018
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 CFAP54	5.26e-04	172	41	3	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE ASTN2 CFAP54	5.26e-04	172	41	3	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GLUL CD36 GALNT4	5.26e-04	172	41	3	0b247fe57163af08132db8df42e6757699885295
ToppCell	droplet-Spleen-SPLEEN-30m-Hematologic-erythroblast\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLUL MPO CD36	5.35e-04	173	41	3	a8fb8db6061fa4d8d56a7b45004ecbd344501573
ToppCell	ILEUM-non-inflamed-(3)_Inf._Macrophages\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GLUL PADI4 CD36	5.35e-04	173	41	3	a8db746992a915a8431ac5c155612e89c4af3cad
ToppCell	3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Lymphocytic-T\|bone_marrow / Manually curated celltypes from each tissue	MPO MAPK14 ACTR2	5.44e-04	174	41	3	1e289b26e2c29dbad15b712a999b96c391a26129
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA TMEM131 POMGNT2	5.44e-04	174	41	3	0fccd90ef72ec2e5eb369fe6d6d126c60886485a
ToppCell	10x5'-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_small-bowel / Manually curated celltypes from each tissue	GLUL PADI4 CD36	5.44e-04	174	41	3	05d54a36772f096047521e16a89cc42ae48d2a1d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE PIK3C2G ANO3	5.44e-04	174	41	3	b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE PIK3C2G ANO3	5.44e-04	174	41	3	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL20RA TMEM131 POMGNT2	5.44e-04	174	41	3	b2fc2a756f8e373ad903bd416d9de703d945fa1c
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	IL20RA CP PTPRR	5.44e-04	174	41	3	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma\|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9	IL20RA ABCA9 CD36	5.53e-04	175	41	3	2eca4c168dea2017ea0e383006e28abed22f32ec
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRHDE PIK3C2G ANO3	5.62e-04	176	41	3	40993c41c1017b53039a337174fc56632b278609
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CP PHOSPHO2 CD36	5.62e-04	176	41	3	1df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCell	COVID-19-kidney-PCT-S3-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GLYATL1 CP PIK3C2G	5.62e-04	176	41	3	b6497324e3e52f514ce556a3fa0c3011c45dcc7b
ToppCell	facs-Heart-LV\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MPO PTPRR CD36	5.62e-04	176	41	3	483e36d9bb7268bf179e69a65e1a0be099035162
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	IL20RA CP PTPRR	5.72e-04	177	41	3	a4c001a8e44142babf9f24dfe6f7b73a70b11b16
Drug	SB 239063	MPO MAPK14 MAPK11	2.77e-06	16	40	3	CID000005166
Drug	L0168	MPO MAPK14 MAPK11	6.54e-06	21	40	3	CID000445856
Drug	SKF86002	MPO MAPK14 MAPK11	9.91e-06	24	40	3	CID000005228
Drug	VX-745	MAPK14 MAPK11 EPHA2	1.12e-05	25	40	3	CID003038525
Drug	Ac2-26	MAPK14 MAPK11	1.80e-05	4	40	2	CID000568638
Drug	NSC-68458	MAPK14 MAPK11	1.80e-05	4	40	2	CID000249771
Drug	dansyl lysine	STK36 CP	1.80e-05	4	40	2	CID000121945
Drug	AC1Q6QQG	MPO CP	3.00e-05	5	40	2	CID000124376
Drug	tolyltriazole	MAPK14 MAPK11	4.49e-05	6	40	2	CID000025902
Drug	AC1NBV4F	MPO CD36	4.49e-05	6	40	2	CID004474233
Drug	12-HPETE	MPO MAPK14 MAPK11	5.90e-05	43	40	3	CID000001415
Drug	2,2',4,6-tetrachlorobiphenyl	MAPK14 MAPK11	6.28e-05	7	40	2	CID000044163
Drug	CID6325568	MAPK14 MAPK11	6.28e-05	7	40	2	CID006325568
Drug	Cp-38	MAPK14 MAPK11	6.28e-05	7	40	2	CID006918286
Drug	satratoxin H	MAPK14 MAPK11	6.28e-05	7	40	2	CID000434380
Drug	1c88	PADI4 MAPK14 MAPK11 GTF2IRD1	7.00e-05	126	40	4	CID000444766
Drug	CNI-1493	MPO MAPK14 MAPK11	7.72e-05	47	40	3	CID005745214
Drug	Z-D-CH2DCB	MAPK14 MAPK11	8.37e-05	8	40	2	CID009911778
Drug	SCH 442416	GLUL MPO	8.37e-05	8	40	2	ctd:C416650
Drug	ML3403	MAPK14 MAPK11	8.37e-05	8	40	2	CID006419739
Drug	ABT-491	MPO PAFAH1B2	8.37e-05	8	40	2	CID000154086
Drug	benzenesulfonyl fluoride	MAPK14 MAPK11 PAFAH1B2	8.75e-05	49	40	3	CID000067779
Drug	edaravone	MPO MAPK14 MAPK11	8.75e-05	49	40	3	CID000004021
Drug	methyl salicylate	GLUL MAPK14 MAPK11	9.87e-05	51	40	3	CID000004133
Drug	SC68376	MAPK14 MAPK11	1.08e-04	9	40	2	CID000005174
Drug	SIN-1 chloride	MPO MAPK14 MAPK11	1.11e-04	53	40	3	CID000065388
Drug	heme b	MPO CP PHOSPHO2 MAPK14 MAPK11 KLHL23	1.16e-04	444	40	6	CID000004973
Drug	AC1NOLIT	MAPK14 MAPK11	1.34e-04	10	40	2	CID005090286
Drug	AC1L1CFC	FLII MAPK14 MAPK11	1.45e-04	58	40	3	CID000001874
Drug	nemorosone	MAPK14 MAPK11	1.64e-04	11	40	2	CID000637105
Drug	Narea	GLUL MPO	1.64e-04	11	40	2	CID000016556
Drug	sorafenib	STK36 MAPK14 MAPK11 EPHA2	1.68e-04	158	40	4	CID000216239
Drug	sesamolin	MAPK14 MAPK11	1.96e-04	12	40	2	CID000101746
Drug	MDL-28842	MAPK14 MAPK11	1.96e-04	12	40	2	CID006441200
Drug	AC1NUK3C	STK36 MAPK14 GTF2IRD1	2.03e-04	65	40	3	CID005481064
Drug	1pzj	FLII MAPK14 MAPK11 CD36	2.08e-04	167	40	4	CID000447976
Drug	Allopurinol	GLUL MPO MAPK14	2.13e-04	66	40	3	ctd:D000493
Drug	BIRB796	MAPK14 MAPK11 EPHA2	2.13e-04	66	40	3	CID000156422
Drug	APDC	MPO CP MAPK14 MAPK11 PIK3C2G	2.27e-04	318	40	5	CID000065351
Drug	M-HT	GLUL MPO STK36	2.53e-04	70	40	3	CID000001136
Drug	SB-242235	MAPK14 MAPK11	2.70e-04	14	40	2	CID009863367
Drug	Pyrimidines	MAPK14 MAPK11	2.70e-04	14	40	2	ctd:D011743
Drug	SB202474	MAPK14 MAPK11	2.70e-04	14	40	2	CID000005162
Drug	CPI-1189	MAPK14 MAPK11	2.70e-04	14	40	2	CID000151118
Drug	AC1L9IGO	MPO MAPK14 MAPK11 CD36	3.01e-04	184	40	4	CID000445722
Drug	chromium	MPO CP MAPK14 MAPK11 ANO3	3.05e-04	339	40	5	CID000023976
Drug	nitroxyl	MPO IFNGR1 CP MAPK14	3.07e-04	185	40	4	CID000000945
Drug	Aluminum Oxide	MPO ACTR2 CD36	3.11e-04	75	40	3	ctd:D000537
Drug	H088	IL20RA FLII CP	3.11e-04	75	40	3	CID000004542
Drug	AC1L1GKN	STK36 MAPK14	3.11e-04	15	40	2	CID000003726
Drug	MMP-2 Inhibitor I	MAPK14 MAPK11	3.11e-04	15	40	2	CID000004220
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A	GLUL FBXW4 PADI4 DHX38	3.39e-04	190	40	4	1990_DN
Drug	AEBSF	MAPK14 MAPK11 PIK3C2G PAFAH1B2	3.46e-04	191	40	4	CID000001701
Drug	SD-282	MAPK14 MAPK11	3.56e-04	16	40	2	CID014973220
Drug	AMP 579	MAPK14 MAPK11	3.56e-04	16	40	2	CID006918429
Drug	L-anserine	MPO CP	3.56e-04	16	40	2	CID000011444
Drug	p-nitrophenyl phosphate	MAPK14 MAPK11 PTPRM PTPRR	3.67e-04	194	40	4	CID000000378
Drug	AGEPC	GLUL MPO MAPK14 MAPK11 PAFAH1B2	3.81e-04	356	40	5	CID000461545
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	MPO MAPK14 MAPK11 PAFAH1B2	3.89e-04	197	40	4	3165_DN
Drug	Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ASTN2 MAPK14 MAPK11 ATRX	3.97e-04	198	40	4	1499_UP
Drug	Ambotz208527-57-5	MAPK14 MAPK11	4.03e-04	17	40	2	CID010258704
Drug	dracorhodin	MAPK14 MAPK11	4.03e-04	17	40	2	CID000069509
Drug	kazinol B	MAPK14 MAPK11	4.03e-04	17	40	2	CID000480869
Drug	Amifostine	MPO MAPK14	4.03e-04	17	40	2	ctd:D004999
Drug	uric acid	MPO CP MAPK14 MAPK11	4.05e-04	199	40	4	CID000001175
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	DOCK1 FLII DHX38 PAFAH1B2	4.05e-04	199	40	4	6963_DN
Drug	Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A	MAPK14 ATRX EPHA2 PAFAH1B2	4.12e-04	200	40	4	7459_DN
Drug	cariporide	MPO MAPK14 MAPK11	4.65e-04	86	40	3	CID000151172
Drug	C11102	MAPK14 MAPK11 PTPRR	4.65e-04	86	40	3	CID000443069
Drug	Oxpl	CD36 PAFAH1B2	5.05e-04	19	40	2	CID000194296
Drug	alpha-ketoisovalerate	MAPK14 MAPK11 GTF2IRD1	5.14e-04	89	40	3	CID000000049
Drug	Hemin	MPO MAPK14 MAPK11	5.31e-04	90	40	3	ctd:D006427
Drug	Pyrazoles	MAPK14 MAPK11	5.60e-04	20	40	2	ctd:D011720
Drug	5-chlorouracil	MPO STK36	5.60e-04	20	40	2	CID000015758
Drug	compound 9b	MAPK14 MAPK11	5.60e-04	20	40	2	CID000207510
Drug	AC1OCF3N	MPO PAFAH1B2	5.60e-04	20	40	2	CID006918166
Drug	n-sulfo-2-aminotricarballylate	MAPK14 MAPK11	5.60e-04	20	40	2	CID000135808
Drug	SB 203580	GLUL MPO CP MAPK14 MAPK11	5.64e-04	388	40	5	ctd:C093642
Drug	oleoyl-lysophosphatidic acid	DOCK1 MAPK14 MAPK11 PTPRM PIK3C2G	5.84e-04	391	40	5	CID000003987
Drug	neurokinin-1 receptor antagonist	MPO FLII	6.19e-04	21	40	2	CID001122655
Drug	Caffeic Acid-13C3	MPO MAPK14 MAPK11	6.22e-04	95	40	3	CID000002518
Drug	AG126	MPO MAPK14 MAPK11	6.41e-04	96	40	3	CID000002046
Drug	telmisartan	MPO MAPK14 CD36	6.61e-04	97	40	3	ctd:C084178
Drug	rifaximin	MPO CD36	6.80e-04	22	40	2	ctd:C042734
Drug	AC1L1BHQ	MPO MAPK14 MAPK11 CD36	6.97e-04	230	40	4	CID000001444
Drug	BN 50739	MPO PAFAH1B2	7.44e-04	23	40	2	CID000115002
Drug	3,5,6-trichloro-2-pyridinol	MAPK14 MAPK11	7.44e-04	23	40	2	CID000023017
Drug	tyrphostin B46	MAPK14 MAPK11	7.44e-04	23	40	2	CID000002058
Drug	AC1L1K7T	STK36 MAPK14 MAPK11 PIK3C2G CD36 DHX38	7.68e-04	632	40	6	CID000005376
Drug	epicholesterol	CP MAPK14 MAPK11 ABCA9 CD36 PAFAH1B2	7.93e-04	636	40	6	CID000000304
Drug	lariat	MPO WDSUB1 DHX38	8.32e-04	105	40	3	CID000165706
Drug	trinexapac-ethyl	STK36 CP	8.80e-04	25	40	2	CID000092421
Drug	Hypertensin II	MPO FLII MAPK14 MAPK11 PIK3C2G	8.87e-04	429	40	5	CID000025476
Drug	Fructose	GLUL CP PIK3C2G CD36	8.95e-04	246	40	4	ctd:D005632
Drug	norethisterone oenanthate	MPO FLII WDSUB1	9.27e-04	109	40	3	CID000019688
Drug	AC1NSK9Q	MAPK14 MAPK11	9.52e-04	26	40	2	CID005311233
Drug	CAS 83919-23-7	MAPK14 MAPK11	9.52e-04	26	40	2	CID000004240
Drug	adenosine kinase inhibitor	PHOSPHO2 KLHL23	9.52e-04	26	40	2	CID000001973
Drug	6-OHDA	MPO FLII MAPK14 MAPK11	1.02e-03	255	40	4	CID000004624
Drug	fluperlapine	MPO FLII	1.03e-03	27	40	2	CID000049381
Disease	cyclic adenosine monophosphate measurement	PTPRM CD36	2.29e-04	17	39	2	EFO_0010473
Disease	glucose homeostasis measurement, acute insulin response measurement	ASTN2 PTPRM	2.57e-04	18	39	2	EFO_0006831, EFO_0006896
Disease	osteoporosis (implicated_via_orthology)	IFNGR1 MAPK14	2.87e-04	19	39	2	DOID:11476 (implicated_via_orthology)
Disease	Brain Diseases	MPO CP	5.01e-04	25	39	2	C0006111
Disease	Encephalopathies	MPO CP	5.85e-04	27	39	2	C0085584
Disease	arteriosclerosis (is_marker_for)	IFNGR1 CD36	6.76e-04	29	39	2	DOID:2349 (is_marker_for)
Disease	level of Sphingomyelin (d38:1) in blood serum	FBXW4 SYNE2	7.23e-04	30	39	2	OBA_2045180
Disease	Cholestasis, Extrahepatic	MPO MAPK14	8.23e-04	32	39	2	C0005398
Disease	Arthritis, Experimental	MPO CP	1.29e-03	40	39	2	C0993582
Disease	Arthritis, Adjuvant-Induced	MPO CP	1.29e-03	40	39	2	C0003865
Disease	Arthritis, Collagen-Induced	MPO CP	1.29e-03	40	39	2	C0971858

Protein segments in the cluster

Peptide	Gene	Start	Entry
EVMDQWTLQMGYPVI	TRHDE	586	Q9UKU6
EEMPWRAQMNLYLAG	CFAP54	1476	Q96N23
MDPEGQQQMWQVIRA	ABCA9	1451	Q8IUA7
NYPMENGIVRNWDDM	ACTR2	71	P61160
DEAMGYPMVQQWRVR	ASTN2	846	O75129
WNLQPMNLHGLMDEY	ANO3	741	Q9BYT9
NIWLQEGLDMQMIIY	PIK3C2G	941	O75747
LFDAYMVAQNPGEWM	CP	321	P00450
VGDEVNWYLMGMGNE	CP	976	P00450
QWMQDEMEIGYIQAP	PADI4	346	Q9UM07
PEIMLNWMHYNQTVD	MAPK11	191	Q15759
MLLDNGQEVYMWVGT	FLII	1196	Q13045
PEIMLNWMHYNQTVD	MAPK14	191	Q16539
MEQYGTPNNIDIWMG	MPO	631	P05164
NMEVLVDSWPEYQMV	GLYATL1	41	Q969I3
AMLPGMDLQYVAWRN	POMGNT2	381	Q8NAT1
IDCIMNDEWMQGVPY	NIM1K	316	Q8IY84
MSQNLEPMEYSVVVW	PHOSPHO2	211	Q8TCD6
PGENETYLMQFMEEW	IL20RA	531	Q9UHF4
QGPMINTVDDFWQMV	PTPRR	466	Q15256
SYMLQRWQEDGGVMI	ATRX	1666	P46100
MERYDPNIDQWSMLG	KLHL12	396	Q53G59
YDPEQNEWREIAPMM	KLHL23	481	Q8NBE8
IGKNVYPFDWVIMNM	DOCK1	976	Q14185
YPFDWVIMNMVQNKV	DOCK1	981	Q14185
WIFDVQNPQEVMMNS	CD36	66	P16671
WNTFEFYMQIGEPMI	GALNT4	261	Q8N4A0
GWDLMQNIMNDMPIY	EPHA2	51	P29317
NMEVLVDSWPEYQMV	GLYATL1B	41	A0A0U1RQE8
MPWMQLEDDSLYISQ	FBXW4	121	P57775
GEMWQVVDMAQQEED	LLCFC1	61	Q96L11
ANQISLVQWPMYMVD	GTF2IRD1	931	Q9UHL9
KNDGPEIQQQWMLYM	DNAH2	811	Q9P225
NMNPIVYWEYQIMPQ	IFNGR1	41	P15260
GDSMVQLMQQYEIWR	PAFAH1B2	46	P68402
TQGPMQETIYDFWRM	PTPRM	971	P28827
NQHPWFGMEQEYTLM	GLUL	126	P15104
EQDPGQAQEWMDNLM	SYNE2	3746	Q8WXH0
RLGYWNQQMVPIKEM	SUPT5H	246	O00267
GQQGVTFDLQPMEWM	STK36	811	Q9NRP7
VQPGVAMQEDMWDAD	TMEM131	766	Q92545
PEDNMLNSMYQLWIL	DHX38	916	Q92620
WNTENGQMLAVMEQP	WDSUB1	81	Q8N9V3